No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (5)
Sort:
#001 — EQ 0.05MG BASE/ML
RLDAP
0 patents0 exclusivities▴
INJECTABLE;INJECTION | Approved: Oct 21, 1988
No patent or exclusivity listings for this strength.
#002 — EQ 0.1MG BASE/ML
RLDAP
0 patents0 exclusivities▾
INJECTABLE;INJECTION | Approved: Oct 21, 1988
#003 — EQ 0.5MG BASE/ML
RLDAP
0 patents0 exclusivities▾
INJECTABLE;INJECTION | Approved: Oct 21, 1988
#004 — EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
INJECTABLE;INJECTION | Approved: Jun 12, 1991
#005 — EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**